Lifecare ASA

AGM Information • May 2, 2024

Extraordinary General Meeting

Extraordinary General Meeting

Lifecare AS will hold an Extraordinary General Meeting on May 16th, 2024, at

10:00 (CET).

The notice with complete agenda and documents are available

on https://lifecare.no/events/

(https://eur04.safelinks.protection.outlook.com/?url=https%3A%2F%2Flifecare.no%2Fevents%2F&data=05%7C02%7Casle.wingsternes%40lifecare.no%7C4a63265cf098488ebb4108dc6ab305d6%7Cc5fbb1c64eb045db9f3c6e20ebcd710e%7C0%7C0%7C638502564358975745%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=99J503JrUH0aFS3zfd5ELtDtcVQ%2BKNmiUEwrqgZWN8k%3D&reserved=0).

It will be possible to attend the meeting in person or digitally through

Orgbrain. Shareholders who wish to participate and vote at the Extraordinary

General Meeting must be registered with a userprofile in the meeting portal

Orgbrain (www.orgbrain.no

(https://eur04.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.orgbrain.no%2F&data=05%7C02%7Casle.wingsternes%40lifecare.no%7C4a63265cf098488ebb4108dc6ab305d6%7Cc5fbb1c64eb045db9f3c6e20ebcd710e%7C0%7C0%7C638502564358985770%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C0%7C%7C%7C&sdata=eI6dUbrNndfRVpvLbKYiaF%2FhEb%2BCAd8YUfb%2BP9ffZCs%3D&reserved=0)).

Further information about participation and registration appears from the

notice.

About us

Lifecare AS is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

asle.wingsternes@lifecare.no, +47 41 61 42 52

This information is subject to disclosure under the Norwegian Securities

Trading Act, §5-12. The information was submitted for publication at

2024-05-02 20:41 CEST.